Release Date: November 1, 2008
Expiration Date: October 31, 2009

During this conference many issues were addressed that clinicians face when they care for patients with chronic hepatitis B infection including:

      • What are the optimal antiviral therapies and treatment strategies?

      • When is a liver biopsy needed and are any of the non-invasive approaches to
        detecting l iver disease accurate enough for clinical use?

      • What are the effective treatment approaches for patients who have previously
        failed treatment?

INTENDED AUDIENCE
•
This program will be of interest to primary care providers and infectious disease specialists who provide care to patients with hepatitis B.

LEARNING OBJECTIVES
Upon completion of this CME/CE activity, the participant should be able to:
•
Discuss significant developments in the diagnosis and management of hepatitis B
•
Summarize new drugs and treatment strategies for hepatitis B
•
Describe recent hepatitis therapy toxicity, drug interaction and side effect data and strategies for management
•
Identify new therapeutic strategies to avoid or overcome antiviral resistance
•
Highlight diagnosis and management approaches for hepatitis B in individuals co-infected with HIV
ACCREDITATION AND DESIGNATION STATEMENTS 


PHYSICIANS
Rush University Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Rush University Center designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

 

NURSES
The University of South Florida College of Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. This activity is for 1 contact hour.

 

PHARMACISTS
 The University of Florida College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider for continuing pharmacy education (UPN# 012-999-07-153-H01-P). This educational activity is accredited for 1 hour of continuing education credits. The University of Florida College of Pharmacy will mail statements of Continuing Education Credit within 30 working days after receiving evidence of successful completion of the course. Successful completion includes achieving a score of at least 70% on the test and a completed evaluation form.

 

Supported by an independent educational grant from Gilead Sciences Medical Affairs
Release Date: November 2008. The opinions or views expressed in this educational program are those of the participants and do not necessarily reflect the opinions or recommendations of Gilead Sciences or Rush University Medical Center. Produced in accordance with all ACCME Essential Areas and Elements and Accreditation Policies. Expected time of completion 1 hour. The faculty may have included discussion on unlabeled uses of a commercial product or an investigational use of a product not yet approved for this purpose. Please consult the full prescribing information before using any medication mentioned in this educational program. Expiration Date: October 31, 2009.

*This coverage is not sanctioned by the conference organizers and is not an official
part of the conference proceedings.

Remove your email address from the HIV and Hepatitis.com e-Newsletter database.